Botox 100 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FRJB5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,675
Award facts
- Contract value 100% obligated
- $19,674.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $19,674.67 to DMS Pharmaceutical Group Inc. for 100-unit vials of BOTOX on February 2, 2026, with an ultimate completion date of February 24, 2026. This firm fixed-price delivery order was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as a critical supplier within the federal pharmaceutical supply chain, particularly for Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) designated SPE2DR, which was awarded under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative on November 13, 2025. The IDC carries a $499.9 billion ceiling value and extends through December 31, 2036, positioning the company as a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. The contract authorizes the DLA to issue firm fixed-price delivery orders for comprehensive pharmaceutical products and medical consumables to support recurring medical supply needs of military healthcare facilities worldwide, with BOTOX representing one of numerous specialty pharmaceutical products the contractor supplies to support Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FRJB5?
SPE2DR26FRJB5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 2, 2026.
How much is contract SPE2DR26FRJB5 worth?
The government has obligated $19,675 on SPE2DR26FRJB5.
Is contract SPE2DR26FRJB5 an order under another contract?
Yes. SPE2DR26FRJB5 is a delivery order under SPE2DR25D9245, an indefinite delivery contract.
Was contract SPE2DR26FRJB5 competed?
The extent of competition for SPE2DR26FRJB5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award